Cargando…

Magnetic nanoparticles enhance the cellular immune response of dendritic cell tumor vaccines by realizing the cytoplasmic delivery of tumor antigens

Dendritic cells (DCs)‐based tumor vaccines have the advantages of high safety and rapid activation of T cells, and have been approved for clinical tumor treatment. However, the conventional DC vaccines have some severe problems, such as poor activation of DCs in vitro, low level of antigen presentat...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Linghong, Liu, Zonghua, Wu, Chongjie, Lin, Jiansheng, Liu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013825/
https://www.ncbi.nlm.nih.gov/pubmed/36925683
http://dx.doi.org/10.1002/btm2.10400

Ejemplares similares